Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Eur J Pharmacol

Retrieve available abstracts of 33 articles:
HTML format

Single Articles

    June 2021
  1. BAI S, Wang X, Wu H, Chen T, et al
    Cardioprotective effect of anisodamine against ischemia/reperfusion injury through the mitochondrial ATP-sensitive potassium channel.
    Eur J Pharmacol. 2021;901:174095.
    PubMed     Abstract available

    May 2021
  2. SAPONARA S, Fusi F, Iovinelli D, Ahmed A, et al
    Flavonoids and hERG channels: Friends or foes?
    Eur J Pharmacol. 2021;899:174030.
    PubMed     Abstract available

    April 2021
  3. SILVA EAP, Carvalho JS, Dos Santos DM, Oliveira AMS, et al
    Cardiovascular effects of farnesol and its beta-cyclodextrin complex in normotensive and hypertensive rats.
    Eur J Pharmacol. 2021 Apr 2:174060. doi: 10.1016/j.ejphar.2021.174060.
    PubMed     Abstract available

    February 2021
  4. ZEQUN Z, Yujia W, Dingding Q, Jiangfang L, et al
    Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
    Eur J Pharmacol. 2021;893:173813.
    PubMed     Abstract available

    December 2020
  5. AMSTETTER D, Badt F, Rubi L, Bittner RE, et al
    The bradycardic agent ivabradine decreases conduction velocity in the AV node and in the ventricles in-vivo.
    Eur J Pharmacol. 2020 Dec 17:173818. doi: 10.1016/j.ejphar.2020.173818.
    PubMed     Abstract available

    September 2020
  6. FO Y, Zhang C, Chen X, Liu X, et al
    Chronic sigma-1 receptor activation ameliorates ventricular remodeling and decreases susceptibility to ventricular arrhythmias after myocardial infarction in rats.
    Eur J Pharmacol. 2020 Sep 30:173614. doi: 10.1016/j.ejphar.2020.173614.
    PubMed     Abstract available

    July 2020
  7. KOJIMA A, Fukushima Y, Itoh H, Imoto K, et al
    A computational analysis of the effect of sevoflurane in a human ventricular cell model of long QT syndrome: Importance of repolarization reserve in the QT-prolonging effect of sevoflurane.
    Eur J Pharmacol. 2020 Jul 22:173378. doi: 10.1016/j.ejphar.2020.173378.
    PubMed     Abstract available

    June 2020
  8. ABDULSALAM TM, Hasanin AH, Mohamed RH, El Sayed Badawy A, et al
    Angiotensin receptor-neprilysin inhibitior)thiorphan/irbesartan( decreased ischemic-reperfusion induced ventricular arrhythmias in rat; in vivo study.
    Eur J Pharmacol. 2020 Jun 25:173295. doi: 10.1016/j.ejphar.2020.173295.
    PubMed     Abstract available

    April 2020
  9. RAHM AK, Muller ME, Gramlich D, Lugenbiel P, et al
    Inhibition of cardiac Kv4.3 (Ito) channel isoforms by class I antiarrhythmic drugs lidocaine and mexiletine.
    Eur J Pharmacol. 2020 Apr 29:173159. doi: 10.1016/j.ejphar.2020.173159.
    PubMed     Abstract available

  10. LI LY, Lou Q, Liu GZ, Lv JC, et al
    Sacubitril/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation.
    Eur J Pharmacol. 2020 Apr 20:173120. doi: 10.1016/j.ejphar.2020.173120.
    PubMed     Abstract available

    March 2020
  11. LI Q, Zhai Z, Li J
    Fibroblast growth factor homologous factors are potential ion channel modifiers associated with cardiac arrhythmias.
    Eur J Pharmacol. 2020;871:172920.
    PubMed     Abstract available

    January 2020
  12. GAO H, Huang X, Tong Y, Jiang X, et al
    Urolithin B improves cardiac function and reduces susceptibility to ventricular arrhythmias in rats after myocardial infarction.
    Eur J Pharmacol. 2020 Jan 17:172936. doi: 10.1016/j.ejphar.2020.172936.
    PubMed     Abstract available

    December 2019
  13. WU Y, Hu Z, Wang D, Lv K, et al
    Resiniferatoxin reduces ventricular arrhythmias in heart failure via selectively blunting cardiac sympathetic afferent projection into spinal cord in rats.
    Eur J Pharmacol. 2019;867:172836.
    PubMed     Abstract available

    September 2019
  14. SOUZA DS, Menezes-Filho JER, Santos-Miranda A, Jesus ICG, et al
    Calcium overload-induced arrhythmia is suppressed by farnesol in rat heart.
    Eur J Pharmacol. 2019;859:172488.
    PubMed     Abstract available

    June 2019
  15. JIN X, Jiang Y, Xue G, Yuan Y, et al
    Increase of late sodium current contributes to enhanced susceptibility to atrial fibrillation in diabetic mice.
    Eur J Pharmacol. 2019;857:172444.
    PubMed     Abstract available

    February 2019
  16. PUGSLEY MK, Yong SL, Goldin AL, Hayes ES, et al
    Molecular charge associated with antiarrhythmic actions in a series of amino-2-cyclohexyl ester derivatives.
    Eur J Pharmacol. 2019;844:241-252.
    PubMed     Abstract available

  17. CHENG XY, Chen C, He SF, Huang CX, et al
    Spinal NGF induces anti-intrathecal opioid-initiated cardioprotective effect via regulation of TRPV1 expression.
    Eur J Pharmacol. 2019;844:145-155.
    PubMed     Abstract available

  18. KAMADA R, Yokoshiki H, Mitsuyama H, Watanabe M, et al
    Arrhythmogenic beta-adrenergic signaling in cardiac hypertrophy: The role of small-conductance calcium-activated potassium channels via activation of CaMKII.
    Eur J Pharmacol. 2019;844:110-117.
    PubMed     Abstract available

  19. TEOFILO TM, Duarte GP, Dos Santos Borges R, Dos Santos Aguiar A, et al
    Stimulation of pulmonary vagal C-fibers by trans-4-methyl-beta-nitrostyrene induces bradycardic and depressor reflex in rats: role of vanilloid TRPV1 receptors.
    Eur J Pharmacol. 2019 Feb 1. pii: S0014-2999(19)30081.
    PubMed     Abstract available

    January 2019
  20. ALSUFYANI HA, Docherty JR
    Methylhexaneamine causes tachycardia and pressor responses indirectly by releasing noradrenaline in the rat.
    Eur J Pharmacol. 2019;843:121-125.
    PubMed     Abstract available

    November 2018
  21. JIANG X, Kong B, Shuai W, Shen C, et al
    Loss of MD1 exacerbates myocardial ischemia/reperfusion injury and susceptibility to ventricular arrhythmia.
    Eur J Pharmacol. 2018 Nov 17. pii: S0014-2999(18)30677.
    PubMed     Abstract available

    August 2018
  22. HAN L, Li J
    Canonical Transient Receptor Potential 3 Channels in atrial fibrillation.
    Eur J Pharmacol. 2018 Aug 25. pii: S0014-2999(18)30494.
    PubMed     Abstract available

  23. CHANG CJ, Cheng CC, Chen YC, Higa S, et al
    Factor Xa inhibitors differently modulate electrical activities in pulmonary veins and the sinoatrial node.
    Eur J Pharmacol. 2018;833:462-471.
    PubMed     Abstract available

  24. HEMMERYCKX B, Feng Y, Frederix L, Lox M, et al
    Evaluation of cardiac arrhythmic risks using a rabbit model of left ventricular systolic dysfunction.
    Eur J Pharmacol. 2018;832:145-155.
    PubMed     Abstract available

    June 2018
  25. ZHANG D, Tu H, Wadman MC, Li YL, et al
    Substrates and potential therapeutics of ventricular arrhythmias in heart failure.
    Eur J Pharmacol. 2018 Jun 22. pii: S0014-2999(18)30357.
    PubMed     Abstract available

    April 2018
  26. ALSUFYANI HA, Docherty JR
    Direct and indirect effects of ephedrine on heart rate and blood pressure in vehicle-treated and sympathectomised male rats.
    Eur J Pharmacol. 2018;825:34-38.
    PubMed     Abstract available

    March 2018
  27. CENTURION D, de la Cruz SH, Castillo-Santiago SV, Becerril-Chacon ME, et al
    NaHS prejunctionally inhibits the cardioaccelerator sympathetic outflow in pithed rats.
    Eur J Pharmacol. 2018;823:35-40.
    PubMed     Abstract available

    February 2018
  28. DE LA CRUZ SH, Medina-Terol GJ, Beltran-Ornelas JH, Gomez CB, et al
    Pharmacological evidence that metformin blocks the vasopressor responses mediated by stimulation of alpha1- and alpha2-adrenoceptors in pithed rats.
    Eur J Pharmacol. 2018;820:130-137.
    PubMed     Abstract available

    July 2017
  29. GONDIM ANS, Lara A, Santos-Miranda A, Roman-Campos D, et al
    (-)-Terpinen-4-ol changes intracellular Ca(2+) handling and induces pacing disturbance in rat hearts.
    Eur J Pharmacol. 2017;807:56-63.
    PubMed     Abstract available

    June 2017
  30. COBOS-PUC L, Aguayo-Morales H, Ventura-Sobrevilla J, Luque-Contreras D, et al
    Further analysis of the inhibition by agmatine on the cardiac sympathetic outflow: Role of the alpha2-adrenoceptor subtypes.
    Eur J Pharmacol. 2017;805:75-83.
    PubMed     Abstract available

    April 2017
  31. ZHENG J, Zhao W, Xu K, Chen Q, et al
    Interaction among hERG channel blockers is a potential mechanism of death in caffeine overdose.
    Eur J Pharmacol. 2017;800:23-33.
    PubMed     Abstract available

    March 2017
  32. SIMO VICENS R, Sauter DR, Grunnet M, Diness JG, et al
    Effect of antiarrhythmic drugs on small conductance calcium -activated potassium channels.
    Eur J Pharmacol. 2017 Mar 18. pii: S0014-2999(17)30209.
    PubMed     Abstract available

    November 2016
  33. LUGENBIEL P, Schweizer PA, Katus HA, Thomas D, et al
    Antiarrhythmic gene therapy - will biologics replace catheters, drugs and devices?
    Eur J Pharmacol. 2016;791:264-273.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.